394 related articles for article (PubMed ID: 23327781)
41. Cyclotrons and positron emission tomography radiopharmaceuticals for clinical imaging.
Saha GB; MacIntyre WJ; Go RT
Semin Nucl Med; 1992 Jul; 22(3):150-61. PubMed ID: 1523413
[TBL] [Abstract][Full Text] [Related]
42. The bioconjugation and radiosynthesis of 89Zr-DFO-labeled antibodies.
Zeglis BM; Lewis JS
J Vis Exp; 2015 Feb; (96):. PubMed ID: 25741890
[TBL] [Abstract][Full Text] [Related]
43. The radioprotection management of a PET department with a cyclotron and radiopharmacy laboratory, in accordance with Italian legislation.
Russo AA; Ferrari P; Casale M; Delia R
Radiat Prot Dosimetry; 2011 Sep; 147(1-2):240-6. PubMed ID: 22039292
[TBL] [Abstract][Full Text] [Related]
44. Effective dose to staff members in a positron emission tomography/CT facility using zirconium-89.
Alzimami KS; Ma AK
Br J Radiol; 2013 Oct; 86(1030):20130318. PubMed ID: 23934963
[TBL] [Abstract][Full Text] [Related]
45.
Heskamp S; Raavé R; Boerman O; Rijpkema M; Goncalves V; Denat F
Bioconjug Chem; 2017 Sep; 28(9):2211-2223. PubMed ID: 28767228
[TBL] [Abstract][Full Text] [Related]
46. Preparation of clinical-grade (89) Zr-panitumumab as a positron emission tomography biomarker for evaluating epidermal growth factor receptor-targeted therapy.
Wei L; Shi J; Afari G; Bhattacharyya S
J Labelled Comp Radiopharm; 2014 Jan; 57(1):25-35. PubMed ID: 24448743
[TBL] [Abstract][Full Text] [Related]
47. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.
Miller L; Winter G; Baur B; Witulla B; Solbach C; Reske S; Lindén M
Nanoscale; 2014 May; 6(9):4928-35. PubMed ID: 24675844
[TBL] [Abstract][Full Text] [Related]
48. A new method for radiochemical separation of arsenic from irradiated germanium oxide.
Jennewein M; Qaim SM; Hermanne A; Jahn M; Tsyganov E; Slavine N; Seliounine S; Antich PA; Kulkarni PV; Thorpe PE; Mason RP; Rösch F
Appl Radiat Isot; 2005 Sep; 63(3):343-51. PubMed ID: 15955705
[TBL] [Abstract][Full Text] [Related]
49. Basics and principles of radiopharmaceuticals for PET/CT.
Wadsak W; Mitterhauser M
Eur J Radiol; 2010 Mar; 73(3):461-9. PubMed ID: 20181453
[TBL] [Abstract][Full Text] [Related]
50. Production of Y-86 and other radiometals for research purposes using a solution target system.
Oehlke E; Hoehr C; Hou X; Hanemaayer V; Zeisler S; Adam MJ; Ruth TJ; Celler A; Buckley K; Benard F; Schaffer P
Nucl Med Biol; 2015 Nov; 42(11):842-9. PubMed ID: 26264926
[TBL] [Abstract][Full Text] [Related]
51. Radiochemistry, Production Processes, Labeling Methods, and ImmunoPET Imaging Pharmaceuticals of Iodine-124.
Kumar K; Ghosh A
Molecules; 2021 Jan; 26(2):. PubMed ID: 33466827
[TBL] [Abstract][Full Text] [Related]
52. [Preparation, quality control and thyroid molecule imaging of solid-target based radionuclide ioine-124].
Zhu H; Wang F; Guo XY; Li LQ; Duan DB; Liu ZB; Yang Z
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Apr; 50(2):364-367. PubMed ID: 29643541
[TBL] [Abstract][Full Text] [Related]
53. Developments toward the Implementation of
van der Meulen NP; Hasler R; Talip Z; Grundler PV; Favaretto C; Umbricht CA; Müller C; Dellepiane G; Carzaniga TS; Braccini S
Molecules; 2020 Oct; 25(20):. PubMed ID: 33066650
[No Abstract] [Full Text] [Related]
54. Synthesis and bioimaging of positron-emitting 15O-labeled 2-deoxy-D-glucose of two-minute half-life.
Yorimitsu H; Murakami Y; Takamatsu H; Nishimura S; Nakamura E
Chem Asian J; 2007 Jan; 2(1):57-65. PubMed ID: 17441139
[TBL] [Abstract][Full Text] [Related]
55. Anion exchange and extraction chromatography tandem column isolation of zirconium-89 (
O'Hara MJ; Carter JC; Kellogg CM; Link JM
J Chromatogr A; 2022 Aug; 1678():463347. PubMed ID: 35908511
[TBL] [Abstract][Full Text] [Related]
56. Advancement in Production of Radiotracers.
Hansen SB; Bender D
Semin Nucl Med; 2022 May; 52(3):266-275. PubMed ID: 34836618
[TBL] [Abstract][Full Text] [Related]
57. Measurements and evaluation of the risks due to external radiation exposures and to intake of activated elements for operational staff engaged in the maintenance of medical cyclotrons.
Calandrino R; del Vecchio A; Parisi R; Todde S; De Felice P; Savi A; Pepe A; Mrskova A
Radiat Prot Dosimetry; 2010 Jun; 139(4):477-82. PubMed ID: 20028699
[TBL] [Abstract][Full Text] [Related]
58. Semi-automated production of ⁸⁹Zr-oxalate/⁸⁹Zr-chloride and the potential of ⁸⁹Zr-chloride in radiopharmaceutical compounding.
Lin M; Mukhopadhyay U; Waligorski GJ; Balatoni JA; González-Lepera C
Appl Radiat Isot; 2016 Jan; 107():317-322. PubMed ID: 26595775
[TBL] [Abstract][Full Text] [Related]
59. [PET radiopharmaceuticals: novelties and new possibilities].
Környei J; Mikecz P; Tóth G
Magy Onkol; 2014 Dec; 58(4):245-50. PubMed ID: 25517442
[TBL] [Abstract][Full Text] [Related]
60. [Use of a cyclotron in the production of positron emitting radionuclides].
Martí-Climent J; Peñuelas I; Calvo R; Giménez M; Gámez C; Richter J
Rev Esp Med Nucl; 1999 Aug; 18(4):261-7. PubMed ID: 10481107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
